A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 (Galcanezumab) in Japanese Patients With Migraine
收藏DataCite Commons2025-06-25 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011140/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as Galcanezumab in Japanese participants with migraine.
本研究的核心目的为评估研究药物戈卡奈珠单抗（Galcanezumab）在日本偏头痛受试者中的安全性与有效性。
提供机构：
Vivli
创建时间：
2025-03-03
